Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1
- PMID: 10348802
Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1
Abstract
Disulfiram and its primary metabolite diethyldithiocarbamate are effective mechanism-based inhibitors of cytochrome P-450 2E1 (CYP2E1)1 in vitro. Single-dose disulfiram diminishes CYP2E1 activity in vivo and has been used to identify CYP2E1 participation in human drug metabolism and prevent CYP2E1-mediated toxification. Specificity of single-dose disulfiram toward CYP2E1 in vivo, however, remains unknown. This investigation determined single-dose disulfiram effects on human CYP 2C9, 2C19, 2D6, and 3A4 activities in vivo. In four randomized crossover experiments, volunteers received isoform-selective probes (oral tolbutamide, mephenytoin, dextromethorphan, or i.v. midazolam) on two occasions, 10 h after oral disulfiram or after no pretreatment (controls). Plasma and/or urine parent and/or metabolite concentrations were measured by HPLC or gas chromatography-mass spectrometry. CYP2C9, 2C19, 2D6, and 3A4 activities were determined from the tolbutamide metabolic ratio, 4'-hydroxymephenytoin excretion, and dextromethorphan/dextrorphan ratios in urine and midazolam systemic clearance, respectively. Midazolam clearance (670 +/- 190 versus 700 +/- 240 ml/min, disulfiram versus controls), dextromethorphan/dextrorphan metabolic ratio (0.013 +/- 0.033 versus 0.015 +/- 0.035), 4'-hydroxymephenytoin excretion (122 +/- 22 versus 128 +/- 25 micromol), and tolbutamide metabolite excretion (577 +/- 157 versus 610 +/- 208 micromol) were not significantly altered by disulfiram pretreatment, although the tolbutamide metabolic ratio was slightly diminished after disulfiram (60 +/- 17 versus 81 +/- 40, p <.05). Results show that single-dose disulfiram does not cause clinically significant inhibition of human CYP2C9, 2C19, 2D6, and 3A4 activities in vivo. When single-dose disulfiram is used as an in vivo probe for P-450, inhibition of drug metabolism suggests selective involvement of CYP2E1. Single-dose disulfiram should not cause untoward drug interactions from inhibition of other P-450 isoforms.
Similar articles
-
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x. Br J Clin Pharmacol. 2002. PMID: 11851639 Free PMC article.
-
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.Rapid Commun Mass Spectrom. 2001;15(10):741-8. doi: 10.1002/rcm.290. Rapid Commun Mass Spectrom. 2001. PMID: 11344532
-
Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.Br J Clin Pharmacol. 1999 Dec;48(6):829-38. doi: 10.1046/j.1365-2125.1999.00099.x. Br J Clin Pharmacol. 1999. PMID: 10594487 Free PMC article.
-
Human cytochrome P450s: selectivity and measurement in vivo.Xenobiotica. 1998 Dec;28(12):1095-128. doi: 10.1080/004982598238859. Xenobiotica. 1998. PMID: 9890156 Review. No abstract available.
-
Cytochrome P450 isozymes and antiepileptic drug interactions.Epilepsia. 1995;36 Suppl 5:S8-13. doi: 10.1111/j.1528-1157.1995.tb06007.x. Epilepsia. 1995. PMID: 8806399 Review.
Cited by
-
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.Br J Clin Pharmacol. 2002 Feb;53(2):155-62. doi: 10.1046/j.1365-2125.2002.01522.x. Br J Clin Pharmacol. 2002. PMID: 11851639 Free PMC article.
-
Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.Br J Clin Pharmacol. 2004 Feb;57(2):162-9. doi: 10.1046/j.1365-2125.2003.01973.x. Br J Clin Pharmacol. 2004. PMID: 14748815 Free PMC article. Clinical Trial.
-
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro data.Chem Res Toxicol. 2012 Nov 19;25(11):2285-300. doi: 10.1021/tx300192g. Epub 2012 Sep 27. Chem Res Toxicol. 2012. PMID: 22823924 Free PMC article. Review.
-
Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.Drug Metab Dispos. 2010 Dec;38(12):2286-92. doi: 10.1124/dmd.110.034710. Epub 2010 Sep 8. Drug Metab Dispos. 2010. PMID: 20826547 Free PMC article.
-
Exogenous Modulation of Retinoic Acid Signaling Affects Adult RGC Survival in the Frog Visual System after Optic Nerve Injury.PLoS One. 2016 Sep 9;11(9):e0162626. doi: 10.1371/journal.pone.0162626. eCollection 2016. PLoS One. 2016. PMID: 27611191 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases